Key result
The authors argue that the patient's refractory cardiogenic shock and demise were likely caused by iatrogenic left atrial perforation and myocardial ischemia, rather than dexmedetomidine.
Why the study?
Does dexmedetomidine administration cause refractory cardiogenic shock in the setting of procedural complications?
Population
1 patient from a previously published case report who experienced refractory cardiogenic shock following…
Design
Editorial
Authors
Loading...
This letter challenges a previous case report linking dexmedetomidine to refractory cardiogenic shock, highlighting alternative plausible causes such as iatrogenic perforation and myocardial ischemia.
Does dexmedetomidine administration cause refractory cardiogenic shock in the setting of procedural complications?
This letter challenges a previous case report linking dexmedetomidine to refractory cardiogenic shock, highlighting alternative plausible causes such as iatrogenic perforation and myocardial ischemia.
Fischer et al. (2008) conducted a letter in Refractory cardiogenic shock (n=1). Dexmedetomidine was evaluated. The authors argue that the patient's refractory cardiogenic shock and demise were likely caused by iatrogenic left atrial perforation and myocardial ischemia, rather than dexmedetomidine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: